CN1433421A - 化学方法和中间体 - Google Patents

化学方法和中间体 Download PDF

Info

Publication number
CN1433421A
CN1433421A CN00818735A CN00818735A CN1433421A CN 1433421 A CN1433421 A CN 1433421A CN 00818735 A CN00818735 A CN 00818735A CN 00818735 A CN00818735 A CN 00818735A CN 1433421 A CN1433421 A CN 1433421A
Authority
CN
China
Prior art keywords
group
compound
isoxazole
tetrahydropyridine
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00818735A
Other languages
English (en)
Chinese (zh)
Inventor
M·B·格拉维斯托克
K·E·H·瓦尔伦
D·S·恩尼斯
A·C·柯里
D·艾恩格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1433421A publication Critical patent/CN1433421A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN00818735A 1999-12-03 2000-11-28 化学方法和中间体 Pending CN1433421A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9928499.4 1999-12-03
GBGB9928499.4A GB9928499D0 (en) 1999-12-03 1999-12-03 Chemical processes and intermediates

Publications (1)

Publication Number Publication Date
CN1433421A true CN1433421A (zh) 2003-07-30

Family

ID=10865576

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00818735A Pending CN1433421A (zh) 1999-12-03 2000-11-28 化学方法和中间体

Country Status (22)

Country Link
EP (1) EP1237895A2 (cs)
JP (1) JP2003515539A (cs)
KR (1) KR20020058072A (cs)
CN (1) CN1433421A (cs)
AR (1) AR026700A1 (cs)
AU (1) AU762241B2 (cs)
BG (1) BG106728A (cs)
BR (1) BR0016087A (cs)
CA (1) CA2395052A1 (cs)
CO (1) CO5271712A1 (cs)
CZ (1) CZ20021912A3 (cs)
EE (1) EE200200282A (cs)
GB (1) GB9928499D0 (cs)
HU (1) HUP0204052A2 (cs)
IL (1) IL149641A0 (cs)
IS (1) IS6401A (cs)
MX (1) MXPA02005396A (cs)
NO (1) NO20022605L (cs)
PL (1) PL364762A1 (cs)
SK (1) SK7862002A3 (cs)
WO (1) WO2001040236A2 (cs)
ZA (1) ZA200203876B (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101616588B (zh) * 2006-09-25 2013-09-25 沃克哈特研究中心 取代的哌啶子基苯基噁唑烷酮

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0113297D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
SI1427711T1 (sl) 2001-09-11 2005-12-31 Astrazeneca Ab Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva
EP1443930A1 (en) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
CN1649866A (zh) 2002-02-28 2005-08-03 阿斯特拉曾尼卡有限公司 3－环状基－5－(含氮5－元环)甲基－噁唑烷酮衍生物及其作为抗菌药物的用途
CN1653064A (zh) 2002-02-28 2005-08-10 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及包含它们的药用组合物
DE60304360T2 (de) 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
ATE344036T1 (de) 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP1656370B1 (en) 2003-06-03 2012-08-15 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic compounds and methods of making and using the same
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
JP5534497B2 (ja) 2005-06-08 2014-07-02 メリンタ セラピューティクス，インコーポレイテッド トリアゾール類の合成方法
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064417A2 (en) * 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101616588B (zh) * 2006-09-25 2013-09-25 沃克哈特研究中心 取代的哌啶子基苯基噁唑烷酮

Also Published As

Publication number Publication date
WO2001040236A3 (en) 2002-05-10
HUP0204052A2 (hu) 2003-03-28
NO20022605L (no) 2002-06-26
EE200200282A (et) 2003-06-16
KR20020058072A (ko) 2002-07-12
SK7862002A3 (en) 2003-02-04
BG106728A (en) 2003-02-28
CO5271712A1 (es) 2003-04-30
CA2395052A1 (en) 2001-06-07
MXPA02005396A (es) 2002-11-29
WO2001040236A2 (en) 2001-06-07
AR026700A1 (es) 2003-02-26
CZ20021912A3 (cs) 2002-08-14
IL149641A0 (en) 2002-11-10
IS6401A (is) 2002-05-28
AU762241B2 (en) 2003-06-19
ZA200203876B (en) 2003-08-15
EP1237895A2 (en) 2002-09-11
PL364762A1 (en) 2004-12-13
AU1715601A (en) 2001-06-12
BR0016087A (pt) 2002-08-06
GB9928499D0 (en) 2000-02-02
JP2003515539A (ja) 2003-05-07
NO20022605D0 (no) 2002-05-31

Similar Documents

Publication Publication Date Title
CN1433421A (zh) 化学方法和中间体
Ohmori et al. Total synthesis of bryostatin 3
EP2594569B1 (en) Entecavir synthesis method and intermediate compound thereof
WO1998022451A1 (en) Taxol derivatives
CN1829722A (zh) 区域选择性合成cci－779
CN1660818A (zh) 制备有机化合物的方法
WO2009140932A2 (en) Method of producing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone
WO2008106900A1 (en) Method of manufacturing (3r, 4s) -1- (4-fluorophenyl) -3- [ (3s) -3- (4 -fluorophenyl) -3-hydroxypropyl) ] -4- (4-hyd roxyphenyl) -2-azetidinone
Wessig et al. Enantioselective Preparation of (2R)‐and (2S)‐Azetidine‐2‐carboxylic Acids
US6307064B1 (en) Process to prepare taxol
US20130296558A1 (en) Preparation process of an antiviral drug (entecavir) and intermediates thereof
KR20000075671A (ko) 제약 화합물의 제조 방법
CN1026791C (zh) 膦酸酯的非对映选择制备
Wattanasereekul et al. Synthesis of the 8‐Hydroxy Acid of Jasplakinolide
CN100347179C (zh) 经口给药用碳青霉素烯化合物的新的合成中间体及其制造方法
JP2001500484A (ja) 医薬化合物の製造法
CN1835918A (zh) 外消旋2－{[2－(4－羟基苯基)乙基]硫基}－3－[4－(2－{4－[(甲磺酰基)氧基]苯氧基}乙基)苯基]－丙酸的制备方法
KR20060051371A (ko) 이미다조피란 유도체의 제조방법
US20250115629A1 (en) Chiral synthons for the synthesis of chiral phosphorothioates
KR20160126700A (ko) 스타틴의 중간체, 이의 제조방법 및 이를 이용한 로수바스타틴의 제조방법
CN114554848A (zh) 用于合成吡啶酰胺的方法
JP4523761B2 (ja) 抗腫瘍活性を有する新規化合物、およびその製造方法
CN1233613A (zh) 生产2－磺酰基吡啶衍生物和生产2－{[(2－吡啶基)甲基]硫基}－1h－苯并咪唑衍生物的方法
CN1942477A (zh) 脯氨酸cci－779(与2,2－二(羟基甲基)丙酸的脯氨酸-纳巴霉素42-酯)和使用微生物脂肪酶进行的脯氨酸cci－779和cci－779的两步酶合成
CN1060842A (zh) 新环丁烷衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication